Novartis AG

Pharmaceuticals
Switzerland
2016 Revenue (US$ Millions)$49,436
Revenue Growth (%)-1.89%
Net Income (US$ Millions)$6,712
Earnings Per Share (US$)$2.80
EPS Growth Rate (%)-61.59%
Profit Margin13.58%
Total Equity (US$ Millions)$74,832
Return on Equity (%)8.71%
Long Term Debt (US$ Millions)$17,897
Debt To Equity Ratio (%)0.24%
Total Assets (US$ Millions)$130,124
Current Assets (US$ Millions)$24,931
Current Liabilities (US$ Millions)$22,209
Cost of Goods Sold (US$ Millions)$17,520
Inventory Turnover2.81